Preventing E-cadherin aberrant N-glycosylation at Asn-554 improves its critical function in gastric cancer

Oncogene

Volumn 35, Issue 13, 2016, Pages 1619-1631

  Carvalho, S ^a,b   Catarino, T A ^a   Dias, A M ^a,b   Kato, M ^c   Almeida, A ^d,e   Hessling, B ^f   Figueiredo, J ^a   Gartner, F ^a,b   Sanches, J M ^g   Ruppert, T ^f   Miyoshi, E ^h   Pierce, M ⁱ   Carneiro, F ^a,j,k   Kolarich, D ^d   Seruca, R ^a,j   Yamaguchi, Y ^c   Taniguchi, N ^c   Reis, C A ^a,b,j   Pinho, S S ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c RIKEN   (Japan)

^d MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^h OSAKA UNIVERSITY   (Japan)

ⁱ UNIVERSITY OF GEORGIA   (United States)

^j University of Porto   (Portugal)

^k HOSPITAL DE SÃO JOÃO   (Portugal)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; N ACETYLGLUCOSAMINYLTRANSFERASE; PROTEIN P120; UVOMORULIN; ALPHA-1,6-MANNOSYLGLYCOPROTEIN BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; ASPARAGINE; CADHERIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARAGINE 554 SITE; CALCIUM BINDING; CANCER INHIBITION; CATALYSIS; CELL AGGREGATION; CELL JUNCTION; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DIMERIZATION; GASTRIC CANCER CELL LINE; GASTRIC MUCOSA; GLYCOSYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STABILITY; SITE DIRECTED MUTAGENESIS; STOMACH CARCINOMA; TISSUE SPECIFICITY; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CHEMISTRY; DOG; ENZYME ACTIVE SITE; GENETICS; HT-29 CELL LINE; KNOCKOUT MOUSE; MDCK CELL LINE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHYSIOLOGY; SEQUENCE HOMOLOGY; STOMACH MUCOSA; STOMACH TUMOR; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ASPARAGINE; CADHERINS; CATALYTIC DOMAIN; CELL LINE, TUMOR; DOGS; GASTRIC MUCOSA; GLYCOSYLATION; HT29 CELLS; HUMANS; MADIN DARBY CANINE KIDNEY CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; N-ACETYLGLUCOSAMINYLTRANSFERASES; SEQUENCE HOMOLOGY, AMINO ACID; STOMACH NEOPLASMS;

EID: 84937605601     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.225     Document Type: Article

References (51)

1. Takeichi M. Functional correlation between cell adhesive properties and some cell surface proteins. J Cell Biol 1977; 75: 464-474.
2. Lewis JE, Jensen PJ, Johnson KR, Wheelock MJ. E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci 1994; 107: 3615-3621.
3. Yap AS, Niessen CM, Gumbiner BM. The juxtamembrane region of the cadherin cytoplasmic tail supports lateral clustering, adhesive strengthening, and interaction with p120ctn. J Cell Biol 1998; 141: 779-789.
4. Guilford P. E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 1999; 5: 172-177.
5. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 2008; 65: 3756-3788.
6. Pinho SS, Seruca R, Gartner F, Yamaguchi Y, Gu J, Taniguchi N et al. Modulation of E-cadherin function and dysfunction by N-glycosylation. Cell Mol Life Sci 2011; 68: 1011-1020.
7. Pinho SS, Carvalho S, Marcos-Pinto R, Magalhaes A, Oliveira C, Gu J et al. Gastric cancer: adding glycosylation to the equation. Trends Mol Med 2013; 19: 664-676.
8. Shapiro L, Fannon AM, Kwong PD, Thompson A, Lehmann MS, Grubel G et al. Structural basis of cell-cell adhesion by cadherins. Nature 1995; 374: 327-337.
9. Pertz O, Bozic D, Koch AW, Fauser C, Brancaccio A, Engel J. A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J 1999; 18: 1738-1747.
10. Nelson WJ. Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem Soc Trans 2008; 36: 149-155.
11. Paredes J, Figueiredo J, Albergaria A, Oliveira P, Carvalho J, Ribeiro AS et al. Epithelial E-and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta 2012; 1826: 297-311.
12. Davis MA, Ireton RC, Reynolds AB. A core function for p120-catenin in cadherin turnover. J Cell Biol 2003; 163: 525-534.
13. Hirohashi S, Kanai Y. Cell adhesion system and human cancer morphogenesis. Cancer Sci 2003; 94: 575-581.
14. Zhou F, Su J, Fu L, Yang Y, Zhang L, Wang L et al. Unglycosylation at Asn-633 made extracellular domain of E-cadherin folded incorrectly and arrested in endoplasmic reticulum, then sequentially degraded by ERAD. Glycoconj J 2008; 25: 727-740.
15. Pinho SS, Figueiredo J, Cabral J, Carvalho S, Dourado J, Magalhaes A et al. E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. Biochim Biophys Acta 2013; 1830: 2690-2700.
16. Vester-Christensen MB, Halim A, Joshi HJ, Steentoft C, Bennett EP, Levery SB et al. Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins. Proc Natl Acad Sci USA 2013; 110: 21018-21023.
17. Lommel M, Winterhalter PR, Willer T, Dahlhoff M, Schneider MR, Bartels MF et al. Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. Proc Natl Acad Sci USA 2013; 110: 21024-21029.
18. Pinho SS, Osorio H, Nita-Lazar M, Gomes J, Lopes C, Gartner F et al. Role of E-cadherin N-glycosylation profile in a mammary tumor model. Biochem Biophys Res Commun 2009; 379: 1091-1096.
19. Gu J, Sato Y, Kariya Y, Isaji T, Taniguchi N, Fukuda T. A Mutual regulation between cell ? cell adhesion and N-glycosylation: implication of the bisecting GlcNAc for biological functions. J Proteome Res 2009; 8: 431-435.
20. Pinho SS, Reis CA, Paredes J, Magalhaes AM, Ferreira AC, Figueiredo J et al. The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet 2009; 18: 2599-2608.
21. de-Freitas-Junior JC, Carvalho S, Dias AM, Oliveira P, Cabral J, Seruca R et al. Insulin/IGF-I signaling pathways enhances tumor cell invasion through bisecting GlcNAc N-glycans modulation. an interplay with E-cadherin. PLoS One 2013; 8: e81579.
22. Yoshimura M, Ihara Y, Matsuzawa Y, Taniguchi N. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 1996; 271: 13811-13815.
23. Kitada T, Miyoshi E, Noda K, Higashiyama S, Ihara H, Matsuura N et al. The addition of bisecting N-acetylglucosamine residues to E-cadherin down-regulates the tyrosine phosphorylation of beta-catenin. J Biol Chem 2001; 276: 475-480.
24. Langer MD, Guo H, Shashikanth N, Pierce JM, Leckband DE. N-glycosylation alters cadherin-mediated intercellular binding kinetics. J Cell Sci 2012; 125: 2478-2485.
25. Varelas X, Bouchie MP, Kukuruzinska M.A. Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling. Glycobiology 2014; 24: 579-591.
26. Nita-Lazar M, Noonan V, Rebustini I, Walker J, Menko AS, Kukuruzinska M.A. Overexpression of DPAGT1 leads to aberrant N-glycosylation of E-cadherin and cellular discohesion in oral cancer. Cancer Res 2009; 69: 5673-5680.
27. Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius KJ, Jarvius J et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006; 3: 995-1000.
28. Przybylo M, Hoja-Lukowicz D, Litynska A, Laidler P. Different glycosylation of cadherins from human bladder non-malignant and cancer cell lines. Cancer Cell Int 2002; 2: 6.
29. Jones J, Krag SS, Betenbaugh MJ. Controlling N-linked glycan site occupancy. Biochim Biophys Acta 20051726. 121-137.
30. Gavel Y, von Heijne G. Sequence differences between glycosylated and nonglycosylated Asn-X-Thr/Ser acceptor sites: implications for protein engineering. Protein Eng 1990; 3: 433-442.
31. Bause E. Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes. Biochem J 1983; 209: 331-336.
32. Oda T, Kanai Y, Oyama T, Yoshiura K, Shimoyama Y, Birchmeier W et al. E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 1994; 91: 1858-1862.
33. Jensen PH, Karlsson NG, Kolarich D, Packer NH. Structural analysis of N-and O-glycans released from glycoproteins. Nat Protoc 2012; 7: 1299-1310.
34. Deshpande N, Jensen PH, Packer NH, Kolarich D. GlycoSpectrumScan: fishing glycopeptides from MS spectra of protease digests of human colostrum sIgA. J Proteome Res 2010; 9: 1063-1075.
35. Thaysen-Andersen M, Packer NH. Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching. Glycobiology 2012; 22: 1440-1452.
36. Liwosz A, Lei T, Kukuruzinska M.A. N-glycosylation affects the molecular organization and stability of E-cadherin junctions. J Biol Chem 2006; 281: 23138-23149.
37. Gu J, Isaji T, Xu Q, Kariya Y, Gu W, Fukuda T et al. Potential roles of N-glycosylation in cell adhesion. Glycoconj J 2012; 29: 599-607.
38. Guo HB, Johnson H, Randolph M, Pierce M. Regulation of homotypic cell-cell adhesion by branched N-glycosylation of N-cadherin extracellular EC2 and EC3 domains. J Biol Chem 2009; 284: 34986-34997.
39. Sato Y, Isaji T, Tajiri M, Yoshida-Yamamoto S, Yoshinaka T, Somehara T et al. An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III. J Biol Chem 2009; 284: 11873-11881.
40. Pruitt KD, Tatusova T, Brown GR, Maglott DR. NCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy. Nucleic Acids Res 2012; 40: D130-D135.
41. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-410.
42. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23: 2947-2948.
43. Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 1993; 234: 779-815.
44. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983; 22: 2577-2637.
45. Chou PY, Fasman GD. Prediction of beta-turns. Biophys J 1979; 26: 367-383.
46. Rose PW, Bi C, Bluhm WF, Christie CH, Dimitropoulos D, Dutta S et al. The RCSB Protein Data Bank: new resources for research and education. Nucleic Acids Res 2013; 41: D475-D482.
47. Cooper CA, Gasteiger E, Packer NH. GlycoMod-a software tool for determining glycosylation compositions from mass spectrometric data. Proteomics 2001; 1: 340-349.
48. Ceroni A, Maass K, Geyer H, Geyer R, Dell A, Haslam SM. GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J Proteome Res 2008; 7: 1650-1659.
49. Kolarich D, Rapp E, Struwe WB, Haslam SM, Zaia J, McBride R et al. The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting mass-spectrometry-based glycoanalytic data. Mol Cell Proteomics 2013; 12: 991-995.
50. York WS, Agravat S, Aoki-Kinoshita KF, McBride R, Campbell MP, Costello CE et al. MIRAGE: the minimum information required for a glycomics experiment. Glycobiology 2014; 24: 402-406.
51. Sanches JM, Figueiredo J, Fonseca M, Durães C, Melo S, Esménio S et al. Quantification of mutant E-cadherin using bioimaging analysis of in situ fluorescence microscopy. A new approach to CDH1 missense variants. Eur J Hum Genet 2015; 23: 1072-1079.